Edgewise Therapeutics Inc (EWTX) USD0.0001

Sell:$26.55Buy:$26.64$1.10 (3.97%)

NASDAQ:1.47%
Prices delayed by at least 15 minutes
Sell:$26.55
Buy:$26.64
Change:$1.10 (3.97%)
Prices delayed by at least 15 minutes
Sell:$26.55
Buy:$26.64
Change:$1.10 (3.97%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
30 December 2024
Alan J RussellPresident
Sell
Option/Award related
100,000$27.37$2,737,470.0014,863
24 December 2024
Marc SemigranChief Level Officer
Sell
Option/Award related
27,980$29.66$829,906.398,445
24 December 2024
Marc SemigranChief Level Officer
Sell
Option/Award related
1,729$30.08$52,008.846,716
23 September 2024
John R MooreGeneral Counsel
Sell
Option/Award related
20,922$27.63$578,064.403,252
20 September 2024
Robert Michael CarruthersCFO
Sell
Option/Award related
46,068$28.59$1,316,909.0635,928
20 September 2024
Robert Michael CarruthersCFO
Sell
Regular sell transaction (market)
4,064$28.59$116,174.3231,864
20 September 2024
Behrad Mokhtar-DerakhshanChief Level Officer
Sell
Option/Award related
42,068$29.03$1,221,133.0815,121
20 September 2024
Joanne M DonovanOther Level A
Sell
Regular sell transaction (market)
7,162$28.29$202,602.9514,538
20 September 2024
Alan J RussellPresident
Sell
Option/Award related
74,185$28.25$2,096,052.6613,534
20 September 2024
Alan J RussellPresident
Sell
Option/Award related
815$29.51$24,048.5312,719

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 January 2024
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
454,545$11.00$4,999,995.0014,436,497
30 December 2024
Alan J RussellPresident
Sell
Option/Award related
100,000$27.37$2,737,470.0014,863
20 September 2024
Alan J RussellPresident
Sell
Option/Award related
74,185$28.25$2,096,052.6613,534
20 September 2024
Robert Michael CarruthersCFO
Sell
Option/Award related
50,000$28.55$1,427,385.006,904
23 January 2024
Robert Michael CarruthersCFO
Sell
Option/Award related
90,000$15.78$1,419,759.0029,024

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.